Research Library

Field trial of billings ovulation method of natural family planning.

Bhargava H et al. Contraception. 1996.

​

Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors.

de Winter JP et al. Mol Cell Endocrinol. 1996.

​

Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women.

Spitzer WO et al. BMJ. 1996.

​

Epithelial Ovarian Cancer: Epidemiology, Screening, and Prevention in Menopausal Medicine (1996)

Bass KM. 1996.

​

Chronic Pelvic Pain. ACOG Technical Bulletin. No. 223

Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. 1996.

​

Infertility in Novak's Gynecology, 12th Edition

Hornstin MD et al. 1996.

​

Procreation after Death or Mental Incompetence: Medical Advance or Technology Gone Awry?

Ohl DA et al. 1996.

​

Correlation between cytokine levels of amniotic fluid and histological chorioamnionitis in preterm delivery.

Negishi H et al. J Perinat Med. 1996.

​

Obstetrics: Normal and Problem Pregnancies

Gabbe SG et al. 1996.

​

Endometriosis and Spontaneous Abortion in Infertility and Reproductive Medicine Clinics of North America

Daya S. 1996.

​

Endometriosis: The Immunoendocrine Factor

Johnson KM. 1996.

​

The Length of the Cervix and the Risk of Spontaneous Premature Delivery

Iams JD et al. 1996.

​

Low and conventional dose transdermal oestradiol are equally effective at preventing bone loss in spine and femur at all post-menopausal ages.

Evans SF et al. Clin Endocrinol (Oxf). 1996.

​

Polycystic ovary syndrome: pathophysiology and outcome with in vitro fertilization.

Buyalos RP et al. Fertil Steril. 1996.

​

Indications for and Technique of Myomectomy in Infertile Reproductive Medicine Clinical North America

Peacock LM et al. 1996.

​

Postpartum Depressive Disorders

Susman JL. 1996.

​

Endocrine Factors in Recurrent Miscarriage

Regan L. 1996.

​

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.

Bloemenkamp KW et al. Lancet. 1995.

​

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.

Jick H et al. Lancet. 1995.

​

Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

No Authors Listed. Lancet. 1995.

​

Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

No Authors Listed. Lancet. 1995.

​

Prophylactic estrogen in recurrent postpartum affective disorder.

Sichel DA et al. Biol Psychiatry. 1995.

​

Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby.

Wilcox AJ et al. N Engl J Med. 1995.

​

Prevention of de-novo adhesion formation after laparoscopic myomectomy: a randomized trial to evaluate the effectiveness of an oxidized regenerated cellulose absorbable barrier.

Mais V et al. Hum Reprod. 1995.

​

Preterm labor: emerging role of genital tract infections.

Andrews WW et al. Infect Agents Dis. 1995.

​